Brad Rouse

Brad Rouse is a seasoned healthcare management executive with a strong background in financial reporting, analysis, reimbursement, and forecasting, focusing on profitability and growth.

His expertise lies in managing mergers and acquisitions, financing, valuation, due diligence, and integration processes, showcasing a successful track record in these areas.

Brad Rouse is a Certified Public Accountant, holding an MBA in Healthcare, Finance, and Accounting from Vanderbilt University, and a BA in Economics from the same institution.

His specialties include Mergers and Acquisitions, Financial Reporting and Analysis, Valuation, Strategy Development, Capital Raising, Reimbursement, Planning and Forecasting, Treasury Management, as well as Board and C-Level Presentations.

Over the course of his career, Brad has held key positions such as Chief Financial Officer at various organizations including Cylinder, Galileo, Wayspring, and Continuum Healthcare, LLC.

He has also served as a Board Member at iO Urology Corp and worked in roles such as Finance and Strategy Consultant at Consultant, Vice President of Finance at Vanguard Health Systems, and Director of Finance at HCA Physician Services.

Before transitioning into healthcare finance, Brad had experiences as an Equity Sales Trader and Fixed Income Analyst at FTN Midwest Securities and FTN Financial, respectively.

Educationally, Brad Rouse has studied at prestigious institutions such as Vanderbilt University's Owen Graduate School of Management for his MBA, and Memphis University School.